Twin Tree Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Hold |
0
| – | – | – | 776 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 742 |
|
|
2021
Q3 | – | Sell |
-16,974
| Closed | -$3.02M | – | 779 |
|
|
2021
Q2 | $3.02M | Buy |
16,974
+7,721
| +83% | +$1.37M | 0.01% | 267 |
|
|
2021
Q1 | $1.52M | Buy |
9,253
+3,231
| +54% | +$531K | 0.01% | 299 |
|
|
2020
Q4 | $994K | Sell |
6,022
-7,646
| -56% | -$1.26M | ﹤0.01% | 328 |
|
|
2020
Q3 | $1.95M | Buy |
13,668
+7,744
| +131% | +$1.1M | 0.01% | 205 |
|
|
2020
Q2 | $654K | Buy |
5,924
+1,752
| +42% | +$193K | ﹤0.01% | 355 |
|
|
2020
Q1 | $416K | Sell |
4,172
-8,376
| -67% | -$835K | ﹤0.01% | 278 |
|
|
2019
Q4 | $1.87M | Buy |
12,548
+3,751
| +43% | +$560K | 0.01% | 200 |
|
|
2019
Q3 | $1.13M | Buy |
8,797
+4,483
| +104% | +$574K | ﹤0.01% | 245 |
|
|
2019
Q2 | $615K | Sell |
4,314
-11,678
| -73% | -$1.66M | ﹤0.01% | 308 |
|
|
2019
Q1 | $2.29M | Buy |
15,992
+14,106
| +748% | +$2.02M | 0.01% | 179 |
|
|
2018
Q4 | $234K | Buy |
+1,886
| New | +$234K | ﹤0.01% | 343 |
|
|
2018
Q2 | – | Sell |
-112
| Closed | -$17K | – | 586 |
|
|
2018
Q1 | $17K | Buy |
+112
| New | +$17K | ﹤0.01% | 408 |
|
|
2017
Q3 | – | Sell |
-1,536
| Closed | -$239K | – | 460 |
|
|
2017
Q2 | $239K | Sell |
1,536
-2,532
| -62% | -$394K | ﹤0.01% | 261 |
|
|
2017
Q1 | $590K | Buy |
+4,068
| New | +$590K | 0.01% | 262 |
|
|
2016
Q4 | – | Sell |
-9,314
| Closed | -$1.13M | – | 531 |
|
|
2016
Q3 | $1.13M | Buy |
+9,314
| New | +$1.13M | 0.01% | 171 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 552 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 564 |
|
|
2015
Q4 | – | Sell |
-795
| Closed | -$106K | – | 573 |
|
|
2015
Q3 | $106K | Sell |
795
-453
| -36% | -$60.4K | ﹤0.01% | 322 |
|
|
2015
Q2 | $220K | Buy |
1,248
+185
| +17% | +$32.6K | 0.01% | 308 |
|
|
2015
Q1 | $184K | Sell |
1,063
-388
| -27% | -$67.2K | ﹤0.01% | 270 |
|
|
2014
Q4 | $238K | Buy |
+1,451
| New | +$238K | 0.01% | 228 |
|